Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 691 AL 705

A systematic review and meta-analysis of cognitive behavioral and psychodynamic therapy for depression in Parkinson's disease patients

Xie CL, Wang XD, Chen J, Lin HZ, Chen YH, Pan JL, Wang WW.

Neurol Sci. 2015 Jun;36(6):833-43. doi: 10.1007/s10072-015-2118-0. Epub 2015 Feb 28.

Drug Interactions in Parkinson's Disease: Safety of Pharmacotherapy for Arterial Hypertension

Bitner A, Zalewski P, Klawe JJ, Newton JL.

Drugs Real World Outcomes. 2015 Mar;2(1):1-12. doi: 10.1007/s40801-015-0008-7.

The discovery of human auditory-motor entrainment and its role in the development of neurologic music therapy

Thaut MH.

Prog Brain Res. 2015;217:253-66. doi: 10.1016/bs.pbr.2014.11.030. Epub 2015 Feb 2.

Neurobiological studies on the relationship between toxoplasmosis and neuropsychiatric diseases

Fabiani S, Pinto B, Bonuccelli U, Bruschi F.

J Neurol Sci. 2015 Apr 15;351(1-2):3-8. doi: 10.1016/j.jns.2015.02.028. Epub 2015 Feb 21.

Tolerance of the VocaLog™ Vocal Monitor by Healthy Persons and Individuals With Parkinson Disease

Searl J, Dietsch AM.

J Voice. 2015 Jul;29(4):518.e13-20. doi: 10.1016/j.jvoice.2014.09.011. Epub 2015 Feb 26.

Hearing and music in dementia

Johnson JK, Chow ML.

Handb Clin Neurol. 2015;129:667-87. doi: 10.1016/B978-0-444-62630-1.00037-8.

Characterization of gastrointestinal disorders in patients with parkinsonian syndromes

Park H, Lee JY, Shin CM, Kim JM, Kim TJ, Kim JW.

Parkinsonism Relat Disord. 2015 May;21(5):455-60. doi: 10.1016/j.parkreldis.2015.02.005. Epub 2015 Feb 14.

Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model

Leão AH, Sarmento-Silva AJ, Santos JR, Ribeiro AM, Silva RH.

Brain Pathol. 2015 Jul;25(4):377-90. doi: 10.1111/bpa.12253. Epub 2015 Apr 22.

Update and Mutational Analysis of SLC20A2: A Major Cause of Primary Familial Brain Calcification

Lemos RR, Ramos EM, Legati A, Nicolas G, Jenkinson EM, Livingston JH, Crow YJ, Campion D, Coppola G, Oliveira JR.

Hum Mutat. 2015 May;36(5):489-95. doi: 10.1002/humu.22778. Epub 2015 Apr 6.

Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain

Roberts RF, Wade-Martins R, Alegre-Abarrategui J.

Brain. 2015 Jun;138(Pt 6):1642-57. doi: 10.1093/brain/awv040. Epub 2015 Mar 1.

Neurosyphilis with psychotic symptoms and Parkinsonism in a young girl

Yin L, Zou S, Huang Y.

Neuropsychiatr Dis Treat. 2015 Feb 16;11:375-7. doi: 10.2147/NDT.S76897. eCollection 2015.

Reversible parkinsonism and cognitive deficits due to vitamin B₁₂ deficiency

Santos AF, Rodrigues M, Abreu P, Ferreira C.

Neurol Sci. 2015 Jun;36(6):1031-2. doi: 10.1007/s10072-015-2126-0. Epub 2015 Mar 4.

Subacute sclerosing panencephalitis with parkinsonian features in a child: A case report

Bozlu G, Cobanogullari Direk M, Okuyaz C.

Brain Dev. 2015 Oct;37(9):901-3. doi: 10.1016/j.braindev.2015.02.008. Epub 2015 Feb 28.

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA; Parkinson's Progression Markers Initiative.

Mov Disord. 2015 Jun;30(7):919-27. doi: 10.1002/mds.26170. Epub 2015 Mar 4.

Biomarkers of cognitive decline in Parkinson's disease

Lin CH, Wu RM.

Parkinsonism Relat Disord. 2015 May;21(5):431-43. doi: 10.1016/j.parkreldis.2015.02.010. Epub 2015 Feb 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias